Search results for "Th2 cytokines"

showing 3 items of 3 documents

Pathological implications of Th1/Th2 cytokine genetic variants in Behçet's disease: Data from a pilot study in a Sicilian population

2013

Cytokines act as pleiotropic polypeptides able to regulate inflammatory/immune responses and to provide important signals in physiological and pathological processes. Several cytokines (Th1, Th2, and Th17) seem to be involved in the pathophysiology of Behçet's disease, a chronic immune-mediated disease characterized by oral and genital lesions and ocular inflammation. Its individual susceptibility seems to be modulated by genetic variants in genes codifying these cytokines. Th1 and Th17 seem to be involved in the disease's active phases, and Th2 seems to affect the development or severity of the disease; however, contrasting data are reported. In this study, some genetic variants of the Th1…

AdultMaleGenotypePopulationPilot ProjectsBehcet's diseaseDiseaseBiologyPolymorphism Single NucleotideBiochemistryYoung AdultImmune systemTh1 and Th2 cytokines Immune imbalance Behc¸et’s disease Polymorphisms SusceptibilityGene FrequencyGenotypeGeneticsmedicineHumansSettore MED/05 - Patologia ClinicaeducationSicilyMolecular BiologyPathologicalEcology Evolution Behavior and SystematicsSettore MED/04 - Patologia Generaleeducation.field_of_studyBehcet SyndromeInterleukinsGenetic VariationGeneral MedicineMiddle Agedmedicine.diseaseHuman geneticsPathophysiologySettore MED/16 - ReumatologiaImmunologyFemale
researchProduct

Treatment of allergic airway inflammation and hyperresponsiveness by antisense-induced local blockade of GATA-3 expression.

2001

Recent studies in transgenic mice have revealed that expression of a dominant negative form of the transcription factor GATA-3 in T cells can prevent T helper cell type 2 (Th2)-mediated allergic airway inflammation in mice. However, it remains unclear whether GATA-3 plays a role in the effector phase of allergic airway inflammation and whether antagonizing the expression and/or function of GATA-3 can be used for the therapy of allergic airway inflammation and hyperresponsiveness. Here, we analyzed the effects of locally antagonizing GATA-3 function in a murine model of asthma. We could suppress GATA-3 expression in interleukin (IL)-4–producing T cells in vitro and in vivo by an antisense ph…

Genetically modified mouseOvalbuminmedicine.medical_treatmentImmunologyT cellsInflammationGATA3 Transcription FactorGATA-3Proinflammatory cytokineMiceTh2 CellsImmunology and AllergyMedicineAnimalsInterleukin 9LungInterleukin 4Mice Inbred BALB Cbiologybusiness.industryInterleukin-9InterleukinOligonucleotides Antisenseasthmaantisense DNADNA-Binding ProteinsEosinophilsOvalbuminCytokineImmunologybiology.proteinTrans-ActivatorsFemaleOriginal ArticleInterleukin-4Th2 cytokinesmedicine.symptomBronchial HyperreactivitybusinessThe Journal of experimental medicine
researchProduct

The Shwartzman reaction repealed

2007

The article, “ -Galactosylceramide induces protection against lipopolysaccharide-induced shock” (doi:10.1189/jlb.0506298), was selected as a Pivotal Advance because the results suggest that -galactosylceramide ( GalCer), a glycolipid isolated from marine sponges, can protect against the complete morbidity and mortality characterisitic of endotoxin shock by inducing NKT cells to produce TH2 cytokines.

Marine sponges1 o (alpha galactopyranosyl) 2 hexacosanoylamino 134 octadecanetriol alpha galactosylceramide lipopolysaccharideImmunologyCell BiologyTh2 cytokinesBiologyNatural killer T cellMicrobiologyEndotoxin shockGlycolipidShock (circulatory)medicineImmunology and Allergylipids (amino acids peptides and proteins)medicine.symptom
researchProduct